Efficacy and Safety of Azithromycin vs Levofloxacin in the Outpatient Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis
- 31 March 2003
- Vol. 123 (3) , 772-777
- https://doi.org/10.1378/chest.123.3.772
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Frequency of pathogen occurrence and antimicrobial susceptibility among community-acquired respiratory tract infections in the respiratory surveillance program study: microbiology from the medical office practice environmentThe American Journal of Medicine, 2001
- Community-Acquired Lower Respiratory Tract InfectionsChest, 2001
- The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitisRespiratory Medicine, 2000
- Do Bacteria Cause Exacerbations of COPD?Chest, 2000
- Pneumococcal macrolide resistance—myth or reality?Journal of Antimicrobial Chemotherapy, 1999
- Infectious exacerbations of chronic bronchitis: diagnosis and managementJournal of Antimicrobial Chemotherapy, 1999
- Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitisJournal of Antimicrobial Chemotherapy, 1999
- Pharmacokinetics in Serum and Leukocyte Exposures of Oral Azithromycin, 1,500 Milligrams, Given over a 3- or 5-Day Period in Healthy SubjectsAntimicrobial Agents and Chemotherapy, 1999
- Definitions, Epidemiology, Pathophysiology, Diagnosis, and StagingAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Antibiotic Therapy in Exacerbations of Chronic Obstructive Pulmonary DiseaseAnnals of Internal Medicine, 1987